Virtus ETF Advisers LLC Relay Therapeutics, Inc. Transaction History

Virtus ETF Advisers LLC

$196 Million
Q2 2024

A detailed history of Virtus ETF Advisers LLC transactions in Relay Therapeutics, Inc. stock. As of the latest transaction made, Virtus ETF Advisers LLC holds 11,569 shares of RLAY stock, worth $75,661. This represents 0.04% of its overall portfolio holdings.

Number of Shares

11,569

Previous 8,702 32.95%

Holding current value

$75,661

Previous $72,000 4.17%

% of portfolio

0.04%

Previous 0.04%

15 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 14, 2024	BUY	$5.9 - $8.02 $16,915 - $22,993	2,867 Added 32.95%	11,569 $75,000
Q1 2024 May 15, 2024	SELL	$7.5 - $12.07 $4,447 - $7,157	-593 Reduced 6.38%	8,702 $72,000
Q4 2023 Feb 15, 2024	BUY	$6.01 - $11.48 $6,148 - $11,744	1,023 Added 12.37%	9,295 $102,000
Q3 2023 Nov 07, 2023	SELL	$8.24 - $12.97 $6,756 - $10,635	-820 Reduced 9.02%	8,272 $69,000
Q2 2023 Aug 14, 2023	BUY	$9.99 - $18.27 $33,026 - $60,400	3,306 Added 57.14%	9,092 $114,000
Q1 2023 May 15, 2023	SELL	$15.0 - $22.76 $33,270 - $50,481	-2,218 Reduced 27.71%	5,786 $95,000
Q4 2022 Feb 14, 2023	BUY	$14.16 - $24.02 $6,768 - $11,481	478 Added 6.35%	8,004 $119,000
Q3 2022 Nov 14, 2022	BUY	$18.07 - $31.37 $903 - $1,568	50 Added 0.67%	7,526 $168,000
Q2 2022 Aug 12, 2022	BUY	$13.31 - $34.88 $25,528 - $66,899	1,918 Added 34.51%	7,476 $125,000
Q1 2022 May 16, 2022	SELL	$20.26 - $32.36 $6,625 - $10,581	-327 Reduced 5.56%	5,558 $166,000
Q4 2021 Feb 14, 2022	SELL	$26.0 - $37.03 $8,528 - $12,145	-328 Reduced 5.28%	5,885 $181,000
Q3 2021 Nov 15, 2021	SELL	$29.75 - $37.99 $9,847 - $12,574	-331 Reduced 5.06%	6,213 $196,000
Q2 2021 Aug 10, 2021	SELL	$27.5 - $38.19 $8,387 - $11,647	-305 Reduced 4.45%	6,544 $239,000
Q1 2021 May 17, 2021	BUY	$32.52 - $61.53 $3,804 - $7,199	117 Added 1.74%	6,849 $237,000
Q4 2020 Feb 12, 2021	BUY	$35.51 - $54.03 $239,053 - $363,729	6,732 New	6,732 $280,000

Others Institutions Holding RLAY

# of Institutions

183

Shares Held

127M

Call Options Held

1.7K

Put Options Held

18K

View Full List

About Relay Therapeutics, Inc.

Ticker RLAY
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 120,219,000
Market Cap $786M
Description
Relay Therapeutics, Inc. operates as a clinical-stage precision medicines company. It engages in transforming the drug discovery process with an initial focus on enhancing small molecule therapeutic discovery in targeted oncology and genetic disease indications. The company's lead product candidates include RLY-4008, an oral small molecule inhib...

More about RLAY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Virtus ETF Advisers LLC, based on Form 13F filings with the SEC.

News

Stay updated on Virtus ETF Advisers LLC with notifications on news.

Account

Virtus ETF Advisers LLC Relay Therapeutics, Inc. Transaction History